X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (42) 42
index medicus (32) 32
animals (25) 25
oncology (24) 24
chemistry (22) 22
human necessities (22) 22
hygiene (22) 22
medical or veterinary science (22) 22
metallurgy (22) 22
preparations for medical, dental, or toilet purposes (22) 22
mice (18) 18
peptides (18) 18
cancer (17) 17
female (17) 17
hematology (17) 17
angiogenesis (16) 16
organic chemistry (15) 15
specific therapeutic activity of chemical compounds ormedicinal preparations (12) 12
male (11) 11
signal transduction (11) 11
cell line, tumor (10) 10
expression (10) 10
middle aged (9) 9
aged (8) 8
biochemistry (8) 8
cell biology (8) 8
cell proliferation (8) 8
cells, cultured (8) 8
neoplasms - pathology (8) 8
vascular endothelial growth factor a - metabolism (8) 8
acute myeloid-leukemia (7) 7
adult (7) 7
beer (7) 7
bone-marrow (7) 7
breast-cancer (7) 7
cells (7) 7
compositions thereof (7) 7
culture media (7) 7
endothelial growth-factor (7) 7
enzymology (7) 7
microbiology (7) 7
microorganisms or enzymes (7) 7
mutation or genetic engineering (7) 7
neovascularization, pathologic - drug therapy (7) 7
propagating, preserving or maintaining microorganisms (7) 7
research (7) 7
spirits (7) 7
tumors (7) 7
vegf (7) 7
vinegar (7) 7
wine (7) 7
activation (6) 6
angiogenesis inhibitors - pharmacology (6) 6
angiogenesis inhibitors - therapeutic use (6) 6
biology (6) 6
care and treatment (6) 6
gene expression regulation, neoplastic (6) 6
in-vivo (6) 6
metastasis (6) 6
mutation (6) 6
neoplasms - blood supply (6) 6
prognosis (6) 6
treatment outcome (6) 6
tumor angiogenesis (6) 6
abridged index medicus (5) 5
antibodies, monoclonal - therapeutic use (5) 5
antineoplastic agents - pharmacology (5) 5
article (5) 5
biochemistry & molecular biology (5) 5
bone marrow (5) 5
growth-factor (5) 5
leukemia, myeloid, acute - drug therapy (5) 5
mice, inbred balb c (5) 5
neovascularization, pathologic - pathology (5) 5
patients (5) 5
placenta growth factor (5) 5
progenitor cells (5) 5
proteins (5) 5
survival (5) 5
therapy (5) 5
vascular endothelial growth factor (5) 5
antibodies, monoclonal - pharmacology (4) 4
apoptosis (4) 4
arrest-specific gene-6 (4) 4
biomarkers (4) 4
breast cancer (4) 4
cell differentiation - drug effects (4) 4
chemotherapy (4) 4
coculture techniques (4) 4
disease models, animal (4) 4
endothelial cells (4) 4
endothelial cells - cytology (4) 4
endothelial progenitor cells (4) 4
endothelium (4) 4
flow cytometry (4) 4
gas6 (4) 4
growth (4) 4
health aspects (4) 4
hypoxia (4) 4
identification (4) 4
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (131) 131
German (11) 11
French (9) 9
Chinese (1) 1
Danish (1) 1
Korean (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
hautnah dermatologie, ISSN 0938-0221, 01/2018, Volume 34, Issue 1, pp. 38 - 48
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2015, Volume 5, p. 207
Lung cancer is the most common cause of cancer-related deaths that frequently metastasizes prior to disease diagnosis. Circulating tumor cells (CTCs) are found... 
Liquid biopsy | Circulating tumor cells | EpCAM | Non-small cell lung cancer | non-small cell lung cancer | REARRANGEMENT | ONCOLOGY | DNA | METASTATIC BREAST-CANCER | BIOLOGY | PROGNOSTIC-SIGNIFICANCE | MUTATIONS | circulating tumor cells | liquid biopsy | CLINICAL-SIGNIFICANCE | Lung cancer, Small cell | Prognosis | Metastasis | Lung cancer, Non-small cell | CTC
Journal Article
Cellular and Molecular Life Sciences, ISSN 1420-682X, 5/2012, Volume 69, Issue 9, pp. 1391 - 1414
Ample clinical and preclinical evidence indicates that macrophages interact with tumor cells as well as with virtually all populations of host cells present in... 
Life Sciences | Biochemistry, general | Life Sciences, general | Tumor-macrophage crosstalk | TAMR (Tyro3, Axl, Mer receptors) | Inflammation | Gas6 | Biomedicine general | TAM (Tumor-associated macrophages) | Cell Biology | Cancer | EXPRESSION ANALYSIS | CANCER-RELATED INFLAMMATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | ARREST-SPECIFIC GENE-6 | NECROSIS-FACTOR-ALPHA | ACUTE MYELOID-LEUKEMIA | CELL BIOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | GROWTH-ARREST | REGULATORY T-CELLS | PROTEIN-S | NF-KAPPA-B | Macrophages - physiology | Leukocytes - pathology | Macrophages - classification | Prognosis | Macrophages - pathology | Fibroblasts - physiology | Humans | Receptor Protein-Tyrosine Kinases - physiology | Male | Leukocytes - physiology | Tumor Microenvironment - physiology | Fibroblasts - pathology | Intercellular Signaling Peptides and Proteins - physiology | Protein S - physiology | Models, Biological | Female | Ligands | Neoplasms - physiopathology | Endothelial Cells - pathology | Neoplasms - pathology | Endothelial Cells - physiology | Macrophages - immunology | Tyrosine | Care and treatment | Genes | Macrophages | Endothelium | Tumors | Kinases | Molecular biology | Cell proliferation | Tumor cells | Malignancy | Leukocytes | Endothelial cells | Axl protein | Reviews | Fibroblasts | Protein-tyrosine kinase receptors | Microenvironments
Journal Article
Scientific Reports, ISSN 2045-2322, 06/2016, Volume 6, Issue 1, p. 28010
Circulating tumour cells (CTCs) serve as valuable biomarkers. However, EpCAM positive CTCs are less frequently detected in NSCLC patients compared to other... 
MESENCHYMAL TRANSITION MARKERS | CIRCULATING TUMOR-CELLS | MULTIDISCIPLINARY SCIENCES | METASTATIC BREAST-CANCER | GROWTH | RESISTANCE | STEM-CELL | PERIPHERAL-BLOOD | PROGNOSTIC-SIGNIFICANCE | EXPRESSION | EGFR
Journal Article
Journal Article
Genes and Cancer, ISSN 1947-6019, 2010, Volume 1, Issue 1, pp. 12 - 25
The concept of inhibiting tumor neovessels has taken the hurdle from the bench to the bedside and now represents an extra pillar of anticancer treatment. So... 
Resistance | Angiogenesis | Novel drug candidates | novel drug candidates | Review | angiogenesis | resistance
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 04/2018, Volume 41, Issue 4, pp. 172 - 180
Lung cancer is the second most common cancer and the leading cause of cancer-related deaths. Different targeted therapies and the introduction of immunotherapy... 
Non-small cell lung cancer, NSCLC | Anti-angiogenesis | Disease management | CONTROLLED-TRIAL | MAINTENANCE BEVACIZUMAB | OPEN-LABEL | ONCOLOGY | BEVACIZUMAB PLUS CHEMOTHERAPY | RANDOMIZED PHASE-III | DOUBLE-BLIND | 1ST-LINE THERAPY | ADJUVANT BEVACIZUMAB | COOPERATIVE-ONCOLOGY-GROUP | ENDOTHELIAL GROWTH-FACTOR | Lung Neoplasms - drug therapy | Bevacizumab - pharmacology | Bevacizumab - therapeutic use | Humans | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Neovascularization, Pathologic - pathology | Angiogenesis Inhibitors - therapeutic use | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Indoles - pharmacology | Molecular Targeted Therapy - methods | Lung Neoplasms - blood supply | Carcinoma, Non-Small-Cell Lung - pathology | Tumor Microenvironment - drug effects | Carcinoma, Non-Small-Cell Lung - blood supply | Antibodies, Monoclonal - pharmacology | Angiogenesis Inhibitors - pharmacology | Treatment Outcome | Randomized Controlled Trials as Topic | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neovascularization, Pathologic - drug therapy | Indoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy
Journal Article